324 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B Downtrend
Article Searches
Alkermes Reports Positive Data From Schizophrenia Study http://www.zacks.com/stock/news/377786/alkermes-reports-positive-data-from-schizophrenia-study?cid=CS-ZC-FT-377786 Apr 10, 2019 - Alkermes (ALKS) reports positive top-line data from phase IIIb study evaluating Aristada and Invega Sustenna in patients with acute exacerbations of schizophrenia.
These 3 Value Stocks Are Absurdly Cheap Right Now https://www.fool.com/investing/2019/04/09/these-3-value-stocks-are-absurdly-cheap-right-now.aspx?source=iedfolrf0000001 Apr 09, 2019 - Good bargains are hard to find in today's market. Here are a few overlooked stocks for you to capitalize on.
Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU http://www.zacks.com/stock/news/371503/pharma-stock-roundup-nvs-inks-immunology-deal-pfe-teva-get-drug-approvals-in-eu?cid=CS-ZC-FT-371503 Apr 05, 2019 - Novartis (NVS) announces plans to acquire IFM Tre, a subsidiary of IFM Therapeutics focused on anti-inflammatory drugs. Pfizer (PFE) & Teva's (TEVA) drugs get regulatory approvals in EU.
Allergan's AMD Drug Lowers Inflammation in Phase III Study http://www.zacks.com/stock/news/370088/allergans-amd-drug-lowers-inflammation-in-phase-iii-study?cid=CS-ZC-FT-370088 Apr 03, 2019 - Allergan's (AGN) MAPLE study evaluating a 12-week dose of abicipar pegol demonstrates decreased intraocular inflammation in nAMD patients.
3 Small-Cap Biotech Stocks to Watch Now https://www.fool.com/investing/2019/04/03/3-small-cap-biotech-stocks-to-watch-now.aspx?source=iedfolrf0000001 Apr 03, 2019 - These under-the-radar stocks could be poised to make big moves in the coming months.
Will Allergan (AGN) Beat Estimates Again in Its Next Earnings Report? http://www.zacks.com/stock/news/369354/will-allergan-agn-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-369354 Apr 02, 2019 - Allergan (AGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Spero Gets Fast Track Designation for SPR994, Shares Improve http://www.zacks.com/stock/news/368643/spero-gets-fast-track-designation-for-spr994-shares-improve?cid=CS-ZC-FT-368643 Apr 01, 2019 - Spero???s (SPRO) SPR994 receives Fast Track designation by the FDA for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis.
The late Agnes Varda saluted by peers for her inventiveness and childlike spirit http://www.latimes.com/entertainment/movies/la-et-mn-agnes-varda-dead-reactions-20190329-story.html Mar 29, 2019 -

French director Agnès Varda, whose landmark films include “Cléo From 5 to 7” (1962) and “Vagabond” (1985), was saluted by her peers on Friday following her death at age 90.

She was a founding spirit of the French New Wave and a visionary creator, and filmmakers, film organizations and other creatives...

Company News For Mar 26, 2019 http://www.zacks.com/stock/news/364668/company-news-for-mar-26-2019?cid=CS-ZC--364668 Mar 26, 2019 - Companies In The News Are: BA, AGN, NKE, VIAB, T
Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus http://www.zacks.com/stock/news/362572/zacks-market-edge-highlights-edwards-lifesciences-exact-sciences-aimmune-therapeutics-allergan-and-evolus?cid=CS-ZC-FT-362572 Mar 21, 2019 - Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus

Pages: 123456...33

Page 1>